Tests used in the analysis of the hemic system.

Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.s. mosquitoes. (1/592)

We investigated the relationship between selected host haematological and parasitological parameters and the density and infectivity of Plasmodium falciparum gametocytes. 143 individuals (age range 1-62 years) attending an outpatient clinic in Farafenni, The Gambia, who had peripheral blood gametocytaemia were recruited (mean gametocyte density 123.7/microl, range 5-17,000/microl). Of the parameters measured, packed cell volume (PCV), reticulocyte count (RetC) and lymphocyte count (LyC) were significantly associated with gametocyte density (r = - 0.17, P < 0.05; r = 0.21, P < 0.01; r = 0.18, P < 0.05, respectively). Data from membrane feeding experiments in which 15 or more mosquitoes were dissected showed that 60.7% (53/87) of gametocyte carriers infected one or more mosquitoes. Gametocyte density was strongly correlated with transmission success (TS) (r = 0.3, P < 0.005) and, in successful infections, with both mosquito prevalence (MP) (r = 0.36, P < 0.005) and mean oocyst burden (MOB) (r = 0.65, P < 0.0001). None of the other factors measured were significantly associated with any of these indices in bivariate analysis. Regression modelling showed that both gametocyte density and PCV were positively associated with gametocyte carrier infectivity to mosquitoes (LRchi2 = 100.7 and 47.2, respectively) and, in successful infections, with MOB (beta = 0.16, t = 4.9, P < 0.001; beta = 0.02, t = 2.3, P < 0.05, respectively). The positive association with PCV suggests that blood meal quality influences infection probably as a nutritional requirement, however, as this effect was most apparent at high gametocyte densities, its epidemiological significance is questionable. Though the haematological parameters associated with gametocyte density are a direct consequence of asexual infection, they may also represent an adaptive mechanism for optimization of sexual stage development.  (+info)

Urinary tract toxicity in rats following administration of beta 3-adrenoceptor agonists. (2/592)

ZD7114, [(S)-4-[2-(2-hydroxy-3 phenoxypropylamine)ethoxy]-N-(2-methoxyethyl) phenoxyacetamide], and ZD2079, [(R)-N-(2-[4- (carboxymethyl)phenoxy]ethyl)-N-(beta-hydroxyphenethyl)ammonium chloride], are beta 3-adrenoceptor stimulants with selectivity for brown adipose tissue. ZD7144 is the hydrochloride salt of the S-enantiomer of the racemic amide ZD2079. They were developed as potential novel treatments for obesity and non-insulin-dependent diabetes mellitus. Male and female rats were dosed separately by gavage for a minimum of 28 days with 0, 10, 50, and 500 mg/kg/day of ZD7114 or with 0, 10, 30, and 150 mg/kg/day of ZD2079. Two further groups of male and female rats were dosed with 0 and 500 mg/kg/day of ZD7114 for 28 days and were then allowed a 6-wk, undosed withdrawal period. At high doses, both compounds caused urinary tract toxicity, which primarily affected the distal tubules and collecting ducts of the kidney via tubular necrosis. They also caused ureteric inflammation, cystitis, and accumulation of crystalline inclusions throughout the urinary tract. As a result of urinary tract toxicity, affected animals from one or both studies showed reduced red blood cell indices, lower platelet counts, and higher white cell counts. Blood chemistry revealed lower plasma concentrations of glucose (7.28 +/- 1.37 compared to 8.11 +/- 0.65 for the control) and total protein (63.42 +/- 3.65 compared to 69.17 +/- 3.24 for the control) and increased plasma urea (37.15 +/- 19.96 compared to 8.09 +/- 0.87 for the control). Urinalysis showed an increase in the number of crystals, blood, and protein. In the urinary tract, the severe crystalluria with accumulation of crystalline material indicated that this may have a role in the etiology of the target organ toxicity. Poor solubility of the compounds at normal urinary pH was considered a possible mechanism for the crystalluria.  (+info)

Effects of carbon dioxide inhalation on hematology, coagulation, and serum clinical chemistry values in rats. (3/592)

Blood samples from adult male and female Charles River Crl:CD (SD) BR rats were collected at weekly intervals for 4 wk to evaluate the effects of inhalation of an anesthetic dose of carbon dioxide (CO2) or of a carbon dioxide-oxygen mixture (CO2/O2) on hematology, coagulation, and serum biochemistry values. During the first 3 wk of the study, rats were assigned to 1 of 3 groups and were bled from the orbital sinus once weekly. Prior to the blood collection, rats in group 1 were exposed to room air only, rats in group 2 received CO2/O2 (approximately 66%:34% CO2:O2) by inhalation, and rats in group 3 received 100% CO2 by inhalation. In the rats exposed to CO2/O2 or CO2, leukocyte counts, lymphocyte counts, and glucose values were higher, and aspartate aminotransferase, creatine kinase, and calcium values were lower compared with those of rats exposed to room air only. Rats exposed to 100% CO2 had slightly (but statistically significant) lower mean corpuscular hemoglobin concentration when compared with rats exposed only to room air. During week 4, all rats were reassigned to 1 of 2 groups and were bled terminally via closed cardiac puncture following exposure to either CO2/O2 or CO2. Increased lymphocyte counts (males only) and glucose and chloride concentrations were noted for rats exposed to CO2/O2 compared with those exposed to CO2. These alterations reiterate the importance of comparing clinical pathology values to those of concurrent control groups that have experienced blood collection under identical conditions in order to avoid potential errors in the interpretation of data.  (+info)

Immunohematological reference ranges for adult Ethiopians. (4/592)

A cross-sectional survey was carried out with 485 healthy working adult Ethiopians who are participating in a cohort study on the progression of human immunodeficiency virus type 1 (HIV-1) infection to establish hematological reference ranges for adult HIV-negative Ethiopians. In addition, enumeration of absolute numbers and percentages of leukocyte subsets was performed for 142 randomly selected HIV-negative individuals. Immunological results were compared to those of 1,356 healthy HIV-negative Dutch blood donor controls. Immunohematological mean values, medians, and 95th percentile reference ranges were established. Mean values were as follows: leukocyte (WBC) counts, 6.1 x 10(9)/liter (both genders); erythrocyte counts, 5.1 x 10(12)/liter (males) and 4.5 x 10(12)/liter (females); hemoglobin, 16.1 (male) and 14.3 (female) g/dl; hematocrit, 48.3% (male) and 42.0% (female); platelets, 205 x 10(9)/liter (both genders); monocytes, 343/microl; granulocytes, 3, 057/microl; lymphocytes, 1,857/microl; CD4 T cells, 775/microl; CD8 T cells, 747/microl; CD4/CD8 T-cell ratio, 1.2; T cells, 1, 555/microl; B cells, 191/microl; and NK cells, 250/microl. The major conclusions follow. (i) The WBC and platelet values of healthy HIV-negative Ethiopians are lower than the adopted reference values of Ethiopia. (ii) The absolute CD4 T-cell counts of healthy HIV-negative Ethiopians are considerably lower than those of the Dutch controls, while the opposite is true for the absolute CD8 T-cell counts. This results in a significantly reduced CD4/CD8 T-cell ratio for healthy Ethiopians, compared to the ratio for Dutch controls.  (+info)

Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. (5/592)

BACKGROUND: Vegetarians have lower platelet and plasma concentrations of n-3 polyunsaturated fatty acids (PUFAs) than do omnivores. We recently showed that male vegetarians have higher platelet aggregability than do omnivores. OBJECTIVE: We investigated whether male vegetarians (n = 17) who consumed an increased amount of dietary alpha-linolenic acid (ALA) showed any changes in their tissue profile of PUFAs, plasma thromboxane concentrations, platelet aggregability, or hemostatic factors. DESIGN: During the study, all subjects maintained their habitual vegetarian diets except that a proportion of dietary fat was replaced with vegetable oils and margarines that were provided. Initially, all subjects consumed a low-ALA diet (containing safflower oil and safflower oil-based margarine) for 14 d; they then consumed either a moderate-ALA diet (containing canola oil and canola oil-based margarine) or a high-ALA diet (containing linseed oil and linseed oil-based margarine) for 28 d. Blood samples were collected at day 0 (baseline), day 14, and day 42. RESULTS: Eicosapentaenoic acid, docosapentaenoic acid, total n-3 PUFAs, and the ratio of n-3 to n-6 PUFAs were significantly increased (P < 0.05), whereas the ratio of arachidonic acid to eicosapentaenoic acid was decreased (P < 0.05), in platelet phospholipids, plasma phospholipids, and triacylglycerols after either the moderate-ALA or high-ALA diet compared with the low-ALA diet. No significant differences were observed in thrombotic risk factors. CONCLUSION: ALA from vegetable oils (canola and linseed) has a beneficial effect on n-3 PUFA concentrations of platelet phospholipids and plasma lipids in vegetarian males.  (+info)

Effects of long-term intake of retinol on selected clinical and laboratory indexes. (6/592)

BACKGROUND: Chemopreventive agents developed to be used in a moderate-risk but otherwise healthy population need to be both efficacious and to have minimal adverse effects. OBJECTIVE: The objective of this study was to evaluate the adverse effects of long-term retinol intake in a skin cancer chemoprevention trial in a large population at moderate risk for skin cancer. DESIGN: Participants (n = 2297) were randomly assigned to receive retinol [7576 retinol equivalents (RE), or 25000 IU] or a placebo daily. The adverse effects of retinol intake were studied by monitoring 14 clinical symptoms and laboratory indexes. The median follow-up time was 3.8 y. RESULTS: No adverse effects concerning the 14 symptoms were observed. Significant differences in alkaline phosphatase (P < 0.0001), triacylglycerol (P < 0.0001), cholesterol (P = 0.04), and HDL (P = 0.01) were observed over time between the 2 groups. After 49 mo of follow-up, alkaline phosphatase was 7% higher, triacylglycerol was 11% higher, cholesterol was 3% higher, and HDL was 1% lower in the retinol group than in the placebo group. CONCLUSIONS: Because a 1% increase in cholesterol concentrations has been reported to be associated with a 2% increase in coronary artery disease risk, long-term ingestion of 7576 RE vitamin A/d should be considered with caution. However, further studies are needed to confirm this finding.  (+info)

Chronic inhalation carcinogenicity study of commercial hexane solvent in F-344 rats and B6C3F1 mice. (7/592)

The carcinogenic and chronic toxicity potential of commercial hexane solvent was evaluated in F-344 rats and B6C3F1 mice (50/sex/concentration/species) exposed by inhalation for 6 h/day, 5 days/week for 2 years. Target hexane vapor concentrations were 0, 900, 3000, and 9000 ppm. There were no significant differences in survivorship between control and hexane-exposed groups, and clinical observations were generally unremarkable. Small, but statistically significant decreases in body weight gain were seen in rats of both sexes in the mid- and high-exposure groups and in high-expsoure female mice. The only noteworthy histopathological finding in rats was epithelial cell hyperplasia in the nasoturbinates and larynx of exposed groups. This response was judged to be indicative of upper respiratory tract tissue irritation. No significant differences in tumor incidence between control and hexane-exposed rats were found. In mice, uterine tissue from the high-exposure females exhibited a significant decrease in the severity of cystic endometrial hyperplasia compared to controls. An increase in the combined incidence of hepatocellular adenomas and carcinomas was observed in high-exposure female mice. The incidence of liver tumors was not increased in the mid- or low-exposure female mice or in male mice exposed to hexane. An increased incidence of pituitary adenomas was observed in female, but not male mice. This finding was not believed to have been treatment-related because the incidence in the control group was unusually low, and the incidence in exposed groups was not dose-related and was within the historical control range. No other neoplastic changes judged to be treatment-related were observed in tissues from male or female mice. In conclusion, chronic exposure to commercial hexane solvent at concentrations up to 9000 ppm was not carcinogenic to F-344 rats or to male B6C3F1 mice, but did result in an increased incidence of liver tumors in female mice.  (+info)

Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. (8/592)

AIMS: To estimate the frequency of adverse drug reactions (ADRs) identified through the use of automatic signals generated from laboratory data (ALS) in hospitalised patients. To determine the frequency of spontaneous recognition of these ADRs by the attending physicians and to assess the potential value of ALS for detection of ADRs. METHODS: Laboratory results of patients hospitalised in a nine bed medical ward were automatically recorded over a period of 17 months. Values exceeding defined boundaries were used as ALS. Charts of every third patient were analysed retrospectively with regard to adverse drug related reactions and causality was evaluated as well as whether the ADR had been recognised during the period of hospitalisation. RESULTS: The charts and ALS of 98 patients were analysed. In 18 cases a drug-related adverse reaction was probable. Awareness to the reaction by the treating physicians was evident in 6 out of these 18 ADRs. Approximately 80% of the ADRs were considered predictable. Three ADRs were regarded as serious. CONCLUSIONS: Adverse drug reactions are common and often preventable. Only one third of ADRs which could have been detected through ALS were recognised by the attending physicians. An increased doctor's awareness of the frequency of drug related abnormal laboratory results by means of ALS is likely to increase the recognition rate of ADRs and might help to prevent them.  (+info)

Hematologic tests, also known as hematology tests, are a group of diagnostic exams that evaluate the health and function of different components of blood, such as red and white blood cells, platelets, and clotting factors. These tests can detect various disorders, including anemia, infection, bleeding problems, and several types of cancer. Common hematologic tests include complete blood count (CBC), coagulation studies, peripheral smear examination, and erythrocyte sedimentation rate (ESR). The specific test or combination of tests ordered will depend on the patient's symptoms, medical history, and physical examination findings.

The ELISA may be an excellent assay to rule out the diagnosis of strongyloidiasis in patients with hematologic malignancies. ... Between April 1995 and December 1998, sera from 164 consecutive patients were tested for the presence of IgG antibody to ... In the present study, we evaluated the enzyme-linked immunosorbent assay (ELISA) in patients with hematologic malignancies. ... The ELISA may be an excellent assay to rule out the diagnosis of strongyloidiasis in patients with hematologic malignancies. ...
Blood Test Indicates Worsening of Multiple Sclerosis One to Two Years Before it Occurs Larissa Warneck - ... First Blood Test for Dozens of Hereditary Cancers Approved by FDA Malorye Branca - ... Hormone Test Identifies Older Women Needing Breast Cancer Preventive Therapy Helen Albert - ...
Hematologic Tests. A complete blood cell (CBC) count may be useful as a marker for infection. Anemia due to hemorrhoidal ... Hematocrit testing is suggested if excessive bleeding with concomitant anemia is suspected. ...
Hematologic tests. Hemoglobin level ,12 g/dL. 777 (39). 46/53 (87). 731/1,913 (38). 10.63 (4.77-23.66). ...
Five hematologic tests and treatments to question. ASH Education Program Book, 2014(1), 599-603 Levinson W, Kallewaard M, ... These unnecessary tests and procedures take away from care by potentially exposing patients to harm, leading to more testing to ... "Medical Associations to Urge Canadas Doctors to Limit Unnecessary Tests". The Globe and Mail. "Unnecessary Medical Tests Need ... Low value cardiac testing and Choosing Wisely. BMJ Qual Saf. 2015 Feb;24(2):89-91. Morden NE, Colla CH, Sequist TD, Rosenthal ...
Hematologic Tests * Humans * Iron / metabolism * Iron Deficiencies* * Male * Sensitivity and Specificity * Tuberculosis / blood ...
Are you plannig to get blood samples for germline DNA testing? Hematologic malignancy testing? Cell free DNA? ... The best test option for screening of CRC is FIT test and consecutively colonoscopy. ... By testing my approach, I found that in one mouse model the data are promising. However, I am looking for validating my data. I ... Hi! The Hazard Ratio test is used in clinical trials. Your example has a HR of 1.07 and the p-value of 0.3966. Hence, the ...
TEST: HEMATOLOGIC DISORDERS BONE MARROW/BONE CORE CHROMOSOME ANALYSIS Purpose of Test: To identify any acquired chromosome ... TEST: HEMATOLOGIC DISORDERS PERIPHERAL BLOOD, UNSTIMULATED CHOMOSOME ANALYSIS Purpose of Test: To identify any acquired ... Click one of the following tests to be taken to it.. Test: Prenatal Amniotic Fluid Chromosome Analysis. Purpose of Test: To ... TEST: CONGENITAL DISORDERS SPECIALIZED GENETIC/BIOCHEMICAL TESTING SKIN BIOPSY FIBROBLAST CULTURE Purpose of Test: Growing of ...
Hematologic testing * Perform the hematologic tests within the time frame specified by the manufacturer of the specific ... Anticoagulant for hematologic testing: * Use tripotassium ethylenediamine tetra-acetate (K3EDTA, 1.5 plus or minus 0.15 mg/mL ... Positive control for testing reagents * Use this control to test the labeling efficiency of new lots of reagents or when the ... Select the appropriate anticoagulant for hematologic testing and flow cytometric immunophenotyping. * ...
Learn about blood count tests, like the complete blood count (CBC). ... Blood count tests help doctors check for certain diseases and conditions. ... ClinicalTrials.gov: Hematologic Tests (National Institutes of Health) Journal Articles References and abstracts from MEDLINE/ ... Platelet Tests (National Library of Medicine) Also in Spanish * RDW Red Cell Distribution Width (National Library of Medicine) ...
Outline available genomic tests for diagnosis of hematologic malignancies and relevant premalignant conditions ... Interpret test results and select appropriate management strategies. *Articulate strategies to explain tests and their ... The following cover the basics of molecular profiling and testing:. *On Target: Terminology Matters: Getting on the Same Page ( ... Patient Points: Explaining the Importance &Implications of Testing (0.5 CE/CME). *On the Horizon: Key Areas of Research in ...
However, in common clinical practice, hematologic testing is unnecessary. The result of a single coagulation procedure has no ... This test fairly closely recreates the distribution of the lytic agent achieved with multiport infusion catheters, particularly ... The initial attempt to traverse the leading edge of the thrombus is described as a guidewire traversal test. The guidewire is ... Some interventionalists advocate the use of tests to monitor the presence of a fibrinolytic state and to predict clinical ...
Smoking, Carboxyhemoglobin, Hematologic Tests. Links. http://pesquisa.bvsalud.org/ghl/resource/en/emro-17036 ...
Categories: Hematologic Tests Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, CopyrightRestricted ...
Hematologic Tests; Decision Making; Pharmaceutical Preparations ... "Providing access to tests such as PrismRA is critical to ... "With more data being generated from tested patients every day, we are continuously serving our provider, payer, and pharma ... From a routine blood draw, the PrismRA test analyzes an individuals molecular signature, helping identify who is unlikely to ... Scipher Medicine will use proceeds to expand commercial efforts for its patient molecular signature test, PrismRA®, ensuring ...
... the leading molecular signature test, to predict which patients with rheumatoid arthritis are unlikely to respond to TNFi ... blinded prospective observational clinical study assessing the ability of the PrismRA test, ... Keywords: Humans; Antirheumatic Agents; Tumor Necrosis Factor Inhibitors; Precision Medicine; Biomarkers; Hematologic Tests; ... Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with Therapy ...
Diagnosis is made from history and exam in patients with known risk factors such as diabetes, but objective test confirmation ... or autonomic-function testing in our academic center during 2013. We determined the prevalence of each abnormal blood-test ... If tests confirm SFPN, and it is "initially idiopathic" (iiSFPN), screening for occult causes is indicated. This studys aim ... Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy J Neurol. 2016 Dec;263(12 ...
Hematologic Genetic Testing in High-risk Patients Before Knee Arthroplasty: A Pilot Study. Clin Orthop Relat Res. 2010 Sep 8. ...
Laboratory Testing of Coagulation Disorders *Clinical Blood Typing and Crossmatching *Testing for Immune-mediated Hematologic ... Genetic Evaluation of Inherited and Acquired Hematologic Disease. Index. click here to see books • videos • cd-roms of related ... Section V. Hematologic Neoplasia. *Cell Cycle Control in Hematopoietic Cells *Epidemiology of Hematopoietic Neoplasia *Genetics ... Diagnostic Test Validation *Reference Intervals *Evaluation of Bone Marrow *Assays for Hematopoietic Precursor Cells * ...
Nervous that your knowledge of organ systems is Skeletal? Dont be! After you Muscle your way through this unit on organ systems, youll be able to discuss how specialized tissues are arranged into organs, and how different organ systems work together to maintain homeostasis, enable reproduction, and respond to environmental threats such as pathogens.
Clinical signs of sepsis have been found to be a more sensitive indicator of neonatal sepsis than hematologic tests (201). ... Rapid testing for group B Streptococcus during labour: a test accuracy study with evaluation of acceptability and cost- ... The development of relatively rapid laboratory tests to identify GBS moves us closer to the possibility of an intrapartum test ... Various streptococcal grouping latex agglutination tests or other tests for GBS detection (e.g., GBS Accuprobe) may be used for ...
Conduct baseline hematologic testing *Hemoglobin ≥10 g/dL. *Platelets ≥100,000/mcL. *Neutrophils >2,000/mcL ... NOTES: Do not share this medication with others.Lab and/or medical tests (such as complete blood count, liver function) should ... 0.2 mg/kg/day PO for 5 days; repeat q4-5Weeks depending on hematologic tolerance ... Hepatic disorders ranging from abnormal liver function tests to clinical manifestations (eg, hepatitis, jaundice) reported ...
... and regular testing of blood glucose, glycosylated hemoglobin, renal function, and hematologic parameters. ... Ames test ( S. typhimurium), gene mutation test (mouse lymphoma cells), or chromosomal aberrations test (human lymphocytes). ... Laboratory Tests. Periodic fasting blood glucose (FBG) and HbA 1c measurements should be performed to monitor therapeutic ... Your doctor will monitor your diabetes and may perform blood tests on you from time to time to make sure your kidneys and your ...
In the majority of patients, initial hematologic laboratory test values were abnormal due to their underlying disease.. ‡ Ten ... Even though the median time to achieve a complete hematologic response was 5 months in study MI400, hematologic responses have ... bone marrow and other diagnostic testing should be made. Monitoring of hematologic parameters should be done regularly (e.g., ... Cytogenetic responses were observed only in patients who had complete hematologic responses. In study DM84-38, hematologic and ...
... testing of blood glucose, glycosylated hemoglobin, renal function, and hematologic parameters. ... Ames test (S. typhimurium), gene mutation test (mouse lymphoma cells), or chromosomal aberrations test (human lymphocytes). ... Your doctor will monitor your diabetes and may perform blood tests on you from time to time to make sure your kidneys and your ... Measurement of hematologic parameters on an annual basis is advised in patients on metformin and any apparent abnormalities ...
Eight had liver function test abnormalities, and six had hematologic test abnormalities. Twenty eight workers reported mucous ... liver and hematologic abnormalities; mucous membrane irritation acute bronchitis ...
These visits included laboratory measurements (hematologic, hepatic, and renal function tests) and imaging (CT or MRI). ... groups were compared using the χ2 or Fisher exact test for categoric variables and the Mann-Whitney U test or the t test for ... PFS and OS were analyzed with the Kaplan-Meier method and the log-rank test. Cox proportional-hazards analysis was used to ... of a cumulative activity of 18.5 or 25.9 GBq was based on the presence of potential risk factors for renal or hematologic ...
Studies are being planned for testing in hematologic malignancies, additional solid tumors and other immunology-focused ...
Studies are being planned for testing in hematologic malignancies, additional solid tumors and other immunology-focused ...

No FAQ available that match "hematologic tests"